Orphazyme Volatility Indicators TRUE RANGE

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>OR</div>
ORPHA -- Denmark Stock  

DKK 104.60  0.80  0.76%

Orphazyme volatility-indicators tool provides you with the Volatility Indicators execution environment for running TRUE RANGE indicator against Orphazyme. Orphazyme volatility indicators enable investors to predict price movements based on how different True Range indicators change over time.
Symbol
Refresh

TRUE RANGE. The output start index for this execution was zero with a total number of output elements of zero. View also all equity analysis or get more info about true range volatility indicators indicator.

Additional Technical Research

About Orphazyme Predictive Technical Analysis

The Macroaxis Predictive Technical Analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Orphazyme AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of Orphazyme AS based on widely used predictive technical indicators. In general, we focus on analyzing Orphazyme stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Orphazyme's daily price indicators and compare them against related drivers such as volatility indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Orphazyme's intrinsic value. In addition to deriving basic predictive indicators for Orphazyme, we also check how macroeconomic factors affect Orphazyme price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Bollinger
Band Projection (param)
LowerMiddle BandUpper
90.7098.89107.08
Details
Hype
Prediction
LowEstimated ValueHigh
100.39104.60108.81
Details
Intrinsic
Valuation
LowReal ValueHigh
81.8186.02115.06
Details
Naive
Forecast
LowNext ValueHigh
110.79115.00119.21
Details
Orphazyme AS, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative orphan diseases. The company was founded in 2009 and is headquartered in Copenhagen, Denmark. Orphazyme is traded on Copenhagen Stock Exchange in Denmark.

Did you try this?

Run Stock Screener Now

   

Stock Screener

Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
All  Next Launch Module

Investors are also interested in

Purchased few shares
Active few hours ago
Please check Your Equity Center. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page